CE – A Gateway to the Global Medtech Market: European Frameworks and the Swiss Reality
Act in compliance with CE requirements while keeping global trends in sight – including the Swiss perspective post-MRA. Discover why “CE + Swiss Quality” will remain a competitive advantage in the future. Concise, strategic, with foresight.
CE marking remains essential for market access in Europe and beyond – but is increasingly challenged by new national certification systems worldwide, particularly in the wake of MDR and IVDR.
This presentation explores how medtech companies can align with EU regulations without losing sight of global shifts. A special focus is placed on the Swiss regulatory landscape following the end of the Mutual Recognition Agreement (MRA).
Learn how “CE + Swiss Quality” can continue to serve as a powerful strategic asset in a changing regulatory environment.
Please note: This presentation will be given in German.
Speakers (1)
